18 September 2024
Ropes & Gray Advises SK Biopharmaceuticals in Worldwide License Agreement with Full-Life Technologies for Radiotherapy Targeting Cancer Cells
Advising firms
Deal team
3 lawyers named| Lawyer | Firm | Seniority | Practice | Office |
|---|---|---|---|---|
| Geoffrey Lin | Ropes & Gray | Partner | IP transactions | Not stated |
| Georgina Jones Suzuki | Ropes & Gray | Counsel | IP transactions | Not stated |
| Derek Mubiru | Ropes & Gray | Associate | IP transactions | Not stated |
Stated terms
- Stated value
- USD 572m ($571.5 million)
- What the figure measures
- Total transaction value
- Client
- Not stated
- Counterparties
- SK Biopharmaceuticals
Full-Life Technologies